Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

The ASOS-2 Trial Maternal Mortality Sub-study

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
Kiungo kimehifadhiwa kwenye clipboard
Hali
Wadhamini
University of Cape Town
Washirika
Bill and Melinda Gates Foundation

Maneno muhimu

Kikemikali

This sub-study is a mixed-methods analysis of a prospective case-series of maternal deaths within the African Surgical OutcomeS-2 trial cohort. The aims of the sub-study are i) to describe the contextual factors that contribute towards maternal deaths after caesarean delivery in Africa using a conceptual framework of "transport-treatment-training" and ii) to classify the maternal deaths in the ASOS-2 trial according to the WHO ICD-10 maternal mortality reporting standard. Data will be extracted from the ASOS-2 trial database. A sub-study case report form (CRF) and semi-structured telephonic interviews will be used to gather additional information from clinicians who were experienced a maternal death during the trial.

Maelezo

This sub-study is a mixed-methods analysis of a prospective case-series of maternal deaths within the African Surgical OutcomeS-2 trial cohort. The aims of the sub-study are i) to describe the contextual factors that contribute towards maternal deaths after caesarean delivery in Africa using a conceptual framework of "transport-treatment-training" and ii) to classify the maternal deaths in the ASOS-2 trial according to the WHO ICD-10 maternal mortality reporting standard. Data will be extracted from the ASOS-2 trial database. When a maternal death is captured on the trial database, the data manager will flag the event. The hospital that registered the death will be contacted and invited to take part in the sub-study. A sub-study case report form (CRF) and semi-structured telephonic interviews will be used to gather additional information from clinicians who were experienced a maternal death during the trial.

This study uses 2 a priori frameworks for describing maternal deaths:

i) The "transport-treatment-training" framework developed by Dr Andrew Shennan (personal communication). This framework suggests that the important determinants (modifiable contextual factors) of maternal mortality can be classified as being related to transport, treatment and training factors.

- Transport refers to the manner in which the patient accesses existing care. This includes decision to seek help, modes of transportation to the hospital, and inter-facility transportation. We consider the healthcare access network in this category.

- Treatment refers to the manner in which the case was managed at the healthcare facility. It includes delays in diagnosis and decision making as well as delays between decision making and physical intervention (e.g. time from decision for caesarean delivery to time of delivery of the infant). Treatment also includes appropriateness of treatment decisions and the availability of resources needed to provide recommended treatment.

- Training refers to the availability of skilled health care providers and the need for training / upskilling of existing health care providers.

ii) The WHO application of ICD-10 codes to deaths during pregnancy, childbirth and puerperium (ICD MM) classification. Within this framework, deaths are described as having a final direct cause, an underlying cause that leads to the final cause, and contributory causes that did not directly cause death, but worsened physiological status or accelerated the underlying event.

The underlying cause of death is defined as the disease or condition that initiated the morbid chain of events leading to death or the circumstances of the accident or violence that produced a fatal injury. Underlying causes will be specified in as much detail as available. The underlying cause will be classified into one of 8 categories:

1. Hypertensive disorders in pregnancy

2. Obstetric haemorrhage

3. Pregnancy-related infection

4. Other obstetric complications

5. Unanticipated complications of management (iatrogenic)

6. Non-obstetric complications (non-obstetric disease, e.g. cardiac disease, malaria)

7. Unknown / Undetermined

8. Coincidental external causes (e.g. interpersonal violence)

Tarehe

Imethibitishwa Mwisho: 12/31/2019
Iliyowasilishwa Kwanza: 06/24/2019
Uandikishaji uliokadiriwa Uliwasilishwa: 07/21/2019
Iliyotumwa Kwanza: 07/22/2019
Sasisho la Mwisho Liliwasilishwa: 01/26/2020
Sasisho la Mwisho Lilichapishwa: 01/28/2020
Tarehe halisi ya kuanza kwa masomo: 05/05/2019
Tarehe ya Kukamilisha Msingi iliyokadiriwa: 07/30/2020
Tarehe ya Kukamilisha Utafiti: 07/30/2020

Hali au ugonjwa

Maternal Mortality
Cesarean Section
Africa

Uingiliaji / matibabu

Procedure: African Surgical OutcomeS-2 Trial

Awamu

-

Vikundi vya Arm

MkonoUingiliaji / matibabu
African Surgical OutcomeS-2 Trial
The ASOS-2 Trial is a cluster randomised trial purposively recruiting hospitals across Africa. To be eligible for inclusion a hospital must perform at least 20 cases of adult in-patient surgery with anaesthesia per week, have local ethics approval for the trial, have local hospital management approval and have established a local hospital study team. The trial excludes hospitals with lower surgical volume. The trial aims to include all consecutive adult in-patient surgical cases at participating hospitals (both elective and emergency surgery). Patients under the age of 18 and patients who have already been recruited into the trial are excluded from recruitment. Follow-up is in-hospital, censored at 30 days.
Procedure: African Surgical OutcomeS-2 Trial
Abdominal, operative delivery of the fetus

Vigezo vya Kustahiki

Zama zinazostahiki Kujifunza 18 Years Kwa 18 Years
Jinsia Inastahiki KujifunzaFemale
Njia ya sampuliNon-Probability Sample
Hupokea Wajitolea wa AfyaNdio
Vigezo

Inclusion Criteria:

- adult patients

- aged 18 years and over,

- admitted to participating hospitals

- undergoing elective and non-elective caesarean delivery

- who die following their operation before leaving hospital and within 30 days after the operation.

Exclusion Criteria:

- prior participation in ASOS-2

- caesarean delivery at a hospital other than the study hospital (left censored)

- patients who are transferred to another hospital before death (right censored)

Matokeo

Hatua za Matokeo ya Msingi

1. Transport: Mode of transport [On the day of hospital admission]

Nominal: walking, private transport, ambulance, public transport

2. Transport: Distance [On the day of hospital admission]

Continuous: distance in kilometers from patient's home to hospital

3. Transport: Time [On the day of hospital admission]

Continuous: time in hours from patient's home to hospital

4. Transport: Delay in seeking healthcare [On the day of hospital admission]

Binary: Obstetrician opinion whether there was a clinically important delay in seeking care

5. Transport: Delay in transport to healthcare [On the day of hospital admission]

Binary: Obstetrician opinion whether there was a clinically important delay in transport

6. Transport: Inter-facility delay [At time of death (death recorded in-hospital, censored at 30 days)]

Binary: Did the patient die while waiting for inter-facility transfer?

7. Treatment: Referral to high level of care [In-hospital censored at 30 days]

Binary: Whether or not referral to higher level of care took place

8. Treatment: Prophylactic uterotonic use [On day of caesarean section, at time of caesarean section]

Nominal: Oxytocin, Ergometrine, Misoprostil, Carbetocin, None

9. Treatment: Therapeutic uterotonic use [On day of caesarean section, at time of caesarean section]

Nominal: Oxytocin, Ergometrine, Misoprostil, Carbetocin, None

10. Treatment: Surgical safety checklist [On day of caesarean section, at time of caesarean section]

Binary: Whether or not a surgical safety checklist was used

11. Treatment: Type of anaesthetic [On day of caesarean section, at time of caesarean section]

Nominal: Regional, general with endotracheal intubation, general without endotracheal intubation.

12. Treatment: Airway aspiration [On day of caesarean section, at time of caesarean section]

Binary: Whether or not airway aspiration occurred

13. Treatment: Desaturation [On day of caesarean section, at time of caesarean section]

Binary: Whether or not desaturation below 90% occurred during management of the airway

14. Treatment: Spinal hypotension [On day of caesarean section, at time of caesarean section]

Binary: Whether or not spinal hypotension occured; systolic BP <= 90mmHg

15. Treatment: Interventions to arrest bleeding [In hospital, censored at 30 days]

Nominal: Which techniques were used? over-sowing, uterine compression suture, uterine artery ligation, uterine tourniquet, intrauterine balloon, hysterectomy, uterine artery embolisation

16. Treatment: Blood products [In hospital, censored at 30 days]

Nominal: Which products were given? Red blood cells, fresh frozen plasma, freeze dried plasma, cryoprecipitate, platelets, whole blood.

17. Treatment: Availability of medications [On day of caesarean section]

Nominal: Oxygen, Propofol, Thiopentone, Etomidate, Ketamine, Suxamethonium, Rocuronium, Nitrous Oxide, Halothane, Isoflurane, Sevoflurane, Oxytocin, Ergometrine, Syntometrine, Misoprostil, Prostaglandin F2alpha, Carbetocin, Phenylephrine, Ephedrine, Adrenalin, Noradrenalin, Morphine, Fentanyl, Pethidine, Lignocaine, Bupivacaine, Tranexamic Acid

18. Treatment: Availability of blood products [On day of caesarean section]

Nominal: Red blood cells, Plasma, Platelets, Cryoprecipitate

19. Treatment: Availability of resuscitation equipment [On day of caesarean section]

Nominal: Airway suction, endotracheal intubation equipment, mechanical ventilator, supraglottic airway devices, defibrillator,

20. Treatment: Availability of monitoring equipment [On day of caesarean section]

Nominal: Which monitoring equipment are available in the recovery area and the postoperative ward? O2 saturation, blood pressure, heart rate monitor, thermometer

21. Treatment: Recovery area [On day of caesarean section]

Binary: Is there a dedicated area where the patient is monitored during recovery from anaesthesia for caesarean section?

22. Treatment: Provider-patient ratio [On day of caesarean section]

Interval: Nurse-to-patient ratio in postoperative ward (during the day, during the night)

23. Treatment: Delay in diagnosis [On day of caesarean section]

Binary: Obstetrician opinion whether a clinical important delay in diagnosis occurred

24. Treatment: Delay between diagnosis and caesarean section [On day of caesarean section]

Binary: Obstetrician opinion whether a clinical important delay between diagnosis and caesarean section occurred

25. Treatment: Access to hospital resources [On day of caesarean section]

Nominal: Obstetrician opinion whether delayed access or lack of hospital resources contributed to the death: water supply, electricity, medications, telephone, anaesthetic equipment, surgical equipment, monitoring equipment, operating theatre, nursing or assistant, on-call senior obstetric doctor, on-call senior anaesthetic doctor, advice from referral center.

26. Training: Level of training [At time of caesarean section]

Nominal: Provider level of training at caesarean seciton (for anaesthesia and surgery): Specialist, specialist trainee, non-specialist doctor, non-doctor

Hatua za Matokeo ya Sekondari

1. Cause of death [Maternal death is recorded in-hospital, censored at 30 days.]

WHO ICD-10 maternal mortality reporting standard

Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge